Skip to main content
Clinical Trials/NCT05096676
NCT05096676
Completed
N/A

Understanding Oxytocin's Neural and Behavioral Effects in Adolescents Diagnosed With Autism

Prof. Ilanit gordon0 sites58 target enrollmentAugust 1, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Autism Spectrum Disorder
Sponsor
Prof. Ilanit gordon
Enrollment
58
Primary Endpoint
The change in social-related neural components (time-locked neural activity) with and without oxytocin
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The investigators explored the neural and behavioral effect of oxytocin on youth with Autism spectrum disorder using magnetoencephalography (MEG). The investigators hypothesize that oxytocin will modulate neural activity to resemble patterns observed in the age-matched control group.

Thirty-two adolescents with autism and 26 typically developing adolescents participated in this randomized, double-blind MEG study. Individuals with autism arrived at the lab twice and received an acute dose of intranasal oxytocin or placebo in each session. During the scans, participants were asked to complete several tasks related to social perception - such as identification of social and non-social stimuli.

Detailed Description

In the current study, the investigators aimed to explore oxytocin's influences on neural components that relate to social processing. Namely, we focused on M100, M170, and M250, which tend to show atypical patterns in individuals with autism. The investigators also examined the effects of oxytocin on time dynamics - the change in specific oscillation over time and its effects on neural connectivity patterns.

Registry
clinicaltrials.gov
Start Date
August 1, 2016
End Date
October 1, 2019
Last Updated
4 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Male

Investigators

Sponsor
Prof. Ilanit gordon
Responsible Party
Sponsor Investigator
Principal Investigator

Prof. Ilanit gordon

Principal Investigator

Bar-Ilan University, Israel

Eligibility Criteria

Inclusion Criteria

  • Males, aged 12-18 years
  • Native Hebrew speakers
  • Normal or corrected-to-normal vision
  • Participants in the ASD group had to meet the criteria for ASD in the diagnostic and statistical manual of mental disorders (DSM-5)

Exclusion Criteria

  • Chronic medical problems
  • Cardiovascular risk factors
  • CNS disease
  • Other mental illnesses
  • Use of prohibited medications
  • Mental retardation
  • Impaired vision
  • Impaired hearing
  • History of significant head injury or neurological illness
  • Current substance dependence diagnosis

Outcomes

Primary Outcomes

The change in social-related neural components (time-locked neural activity) with and without oxytocin

Time Frame: During each session

The amplitude (tesla) of three social related neural components will be measured using MEG device

Secondary Outcomes

  • The change in oscillatory activity - power magnitude of Delta, Theta, Alpha, Beta and Gamma neural bands with and without oxytocin(During each session)
  • The change in behavioral measurments - reaction times and accurecy rates, with and without oxytocin(During each session)

Similar Trials